000 01407 a2200397 4500
005 20250518003350.0
264 0 _c20200106
008 202001s 0 0 eng d
022 _a2530-0180
024 7 _a10.1016/j.endinu.2018.08.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRubio-Almanza, Matilde
245 0 0 _aObesity and type 2 diabetes: Also linked in therapeutic options.
_h[electronic resource]
260 _bEndocrinologia, diabetes y nutricion
_cMar 2019
300 _a140-149 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Obesity Agents
_xtherapeutic use
650 0 4 _aBariatric Surgery
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aComorbidity
650 0 4 _aDiabetes Mellitus, Type 2
_xdiet therapy
650 0 4 _aDiet, Diabetic
650 0 4 _aDiet, Reducing
650 0 4 _aDrug Therapy, Combination
650 0 4 _aForecasting
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xclassification
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aObesity
_xdiet therapy
650 0 4 _aWeight Loss
700 1 _aCámara-Gómez, Rosa
700 1 _aMerino-Torres, Juan Francisco
773 0 _tEndocrinologia, diabetes y nutricion
_gvol. 66
_gno. 3
_gp. 140-149
856 4 0 _uhttps://doi.org/10.1016/j.endinu.2018.08.003
_zAvailable from publisher's website
999 _c28954840
_d28954840